Lenalidomide
Who holds supplier records for Lenalidomide? 20 organisations hold a current record for Lenalidomide: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (13), China (3), South (1), Netherlands (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lenalidomide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lenalidomide
Reading the evidence
- 20 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
13 of the 19 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 14 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Lenalidomide expires 8 Mar 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (20)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lenalidomide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndia Company GMP cert on recordActive DMF 35556, 29628 · latest filing Feb 2021
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 25872, 35505, 29691 · latest filing Dec 2020
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 31960, 31590 · latest filing Sept 2017
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 34650 · latest filing Feb 2020
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 37730 · latest filing Nov 2022
- Biocon LimitedIndiaActive DMF 34956 · latest filing Jul 2020
- CHANGZHOU PHARMACEUTICAL FACTORYChina Company GMP cert on recordActive DMF 31804 · latest filing Jun 2017
- Deva Holding AsCompany GMP cert on recordActive DMF 36440 · latest filing Dec 2021
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 32279 · latest filing Dec 2017
- Kyongbo Pharmaceutical Co., Ltd.SouthActive DMF 35109 · latest filing Apr 2021
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 23410 · latest filing Dec 2009
- Reliance Life Sciences Pvt. Ltd.India Company GMP cert on recordActive DMF 27905 · latest filing Feb 2014
- Shandong Anhong Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 35731 · latest filing Apr 2021
- SHILPA PHARMA LIFESCIENCES LTDIndiaActive DMF 33084 · latest filing Apr 2020
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 31549 · latest filing Dec 2017
- SynthonNetherlands Company GMP cert on recordActive DMF 34724 · latest filing Mar 2020
- VALARY LAB PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 38760 · latest filing Sept 2023
- VERANOVA LPUnited KingdomActive DMF 36810 · latest filing May 2022
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChinaActive DMF 36458 · latest filing Oct 2021
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 27116 · latest filing Jun 2013
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Lenalidomide are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- MYLAN LABORATORIES LTDInactive DMF 24264 · filed Dec 2010
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (113 listed products contain Lenalidomide). The latest listed patent expires 8 Mar 2028. The latest listed exclusivity ended 28 May 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Lenalidomide is a derivative of thalidomide with immunomodulatory and antiangiogenic properties. It is used in the treatment of various types of cancer, particularly multiple myeloma, and certain hematological disorders.
Chemical identity
- IUPAC name
- 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
- Canonical SMILES
- C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
- InChIKey
- GOTYRUGSSMKFNF-UHFFFAOYSA-N
- Synonyms
- Revlimid API, cc-5013, cdc-501, nsc-747972, revlimid, syp-1512
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Thalidomide Analog
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lenalidomide?
20 organisations hold an active US FDA Type II Drug Master File or a CEP for Lenalidomide: Cipla Limited (India), Dr. Reddy's Laboratories Ltd. (India), MSN Laboratories Private Limited (India), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Biocon Limited (India), CHANGZHOU PHARMACEUTICAL FACTORY (China) and Deva Holding As, and 12 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lenalidomide Drug Master Files are active?
Cipla Limited (DMF 35556, 29628), Dr. Reddy's Laboratories Ltd. (DMF 25872, 35505), MSN Laboratories Private Limited (DMF 31960, 31590), Alembic Pharmaceuticals Limited (DMF 34650), APITORIA PHARMA PRIVATE LTD (DMF 37730), Biocon Limited (DMF 34956), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 31804) and Deva Holding As (DMF 36440) and 12 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lenalidomide records mean?
1 organisation has only inactive Type II DMFs for Lenalidomide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Lenalidomide?
Yes. The latest patent listed for an approved US product containing Lenalidomide expires 8 Mar 2028, across 113 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Lenalidomide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lenalidomide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.